Thursday, October 30, 2014

Top 5 Dividend Stocks To Buy Right Now

Linked here is a detailed quantitative analysis of Pepsico, Inc. (PEP). Below are some highlights from the above linked analysis:

Company Description: PepsiCo, Inc. is a major international producer of branded beverage and snack food products.

Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description:

1. Avg. High Yield Price
2. 20-Year DCF Price
3. Avg. P/E Price
4. Graham Number

PEP is trading at a premium to all four valuations above. Since PEP's tangible book value is not meaningful, a Graham number can not be calculated. The stock is trading at a 41.5% premium to its calculated fair value of $60.67. PEP did not earn any Stars in this section.

Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description:

1. Free Cash Flow Payout
2. Debt To Total Capital
3. Key Metrics
4. Dividend Growth Rate
5. Years of Div. Growth
6. Rolling 4-yr Div. > 15%

5 Best Long Term Stocks To Watch Right Now: People's United Financial Inc.(PBCT)

People?s United Financial, Inc. operates as the bank holding company for People?s United Bank that provides commercial banking, retail and business banking, and wealth management services to individual, corporate, and municipal customers. Its Commercial Banking segment provides commercial and industrial lending, commercial real estate lending, and commercial deposit gathering services, as well as equipment financing, cash management, correspondent banking, and municipal banking services. The company?s Retail and Business Banking segment offers consumer and business deposit gathering services; consumer lending products, including residential mortgage, home equity, and indirect auto lending; business lending; and merchant services. Its Wealth Management segment provides trust services, corporate trust, brokerage, financial advisory services, investment management services, and life insurance and other insurance services, as well as private banking services. The company also offers online and telephone banking, and investment trading services, and automated teller machine (ATM) services. As of March 31, 2011, it operated a network of approximately 341 branches, including full-service supermarket branches, investment and brokerage offices, and commercial banking offices, as well as approximately 518 automated teller machines in Connecticut, Vermont, New York, New Hampshire, Maine, and Massachusetts. The company was founded in 1842 and is headquartered in Bridgeport, Connecticut.

Advisors' Opinion:
  • [By Rick Munarriz]

    I went out on a limb last week, and now it's time to see how that decision played out.

    I predicted that People's United Financial (NASDAQ: PBCT  ) would close higher on the week. The regional banker had come up short on the bottom line in its two previous quarters, and the prior week closed with uninspiring earnings news out of the banking behemoths. People's United managed to match expectations on an operating basis, but the market was skeptical of financial services institutions this week. People's United Financial shares closed lower on the week. I was right. I predicted that the tech-heavy Nasdaq would outperform the Dow Jones Industrial Average. (DJINDICES: ^DJI  ) . This has been a tricky call lately, so how did it play out this time? Well, the market was rocked hard this week, and secondary stocks led the way down. The Nasdaq fell 2.7% on the week. The Dow managed to close just 2.1% lower. I was wrong. My final call was for United Rentals (NYSE: URI  ) to beat Wall Street's quarterly profit target. The provider of equipment rentals with 836 outlets across the country has been beating Wall Street estimates consistently over the past year. Why should that end? Analysts were looking for a profit of $0.47 a share during the quarter, and it came through with adjusted net income of $0.58. I was right.

    Two out of three? I can do better than that.

  • [By Dividends4Life]

    Related Articles:
    - People's United Financial Inc. (PBCT) Dividend Stock Analysis
    - Emerson Electric Co. (EMR) Dividend Stock Analysis
    - Archer Daniels Midland Company (ADM) Dividend Stock Analysis
    - AT&T Inc. (T) Dividend Stock Analysis
    - More Stock Analysis

  • [By Dividends4Life]

    Linked here is a detailed quantitative analysis of People's United Financial Inc. (PBCT). Below are some highlights from the above linked analysis:

  • [By Dividends4Life]

    Related Articles
    - Cincinnati Financial Corp. (CINF) Dividend Stock Analysis
    - Exxon Mobil Corporation (XOM) Dividend Stock Analysis
    - People's United Financial Inc. (PBCT) Dividend Stock Analysis
    - Emerson Electric Co. (EMR) Dividend Stock Analysis
    - More Stock Analysis

Top 5 Dividend Stocks To Buy Right Now: Smith & Nephew SNATS Inc.(SNN)

Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the orthopaedics, endoscopy, and advanced wound management sectors worldwide. The company operates in three segments: Orthopaedics, Endoscopy, and Advanced Wound Management. The Orthopaedics segment offers reconstruction implants, including hip, knee, and shoulder joints, as well as ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. This segment also provides trauma fixation products consisting of internal and external devices, and other products, including shoulder fixation and orthobiological materials used in the stabilization of fractures and deformity correction procedures; and clinical therapies products comprising bone growth stimulation, joint fluid therapies, and outpatient spine products. The Endoscopy segment develops and commercializes minimally invasive surgery techniques, educational programs, and value-added services for sur geons to treat and repair soft tissue and articulating joints. It offers specialized devices and fixation systems to repair damaged tissues; fluid management equipment for surgical access; digital cameras, digital image capture, scopes, light sources, and monitors to assist with visualisation; radiofrequency wands, electromechanical and mechanical blades, and hand instruments for resecting damaged tissues. The Advanced Wound Management segment provides initial wound bed preparation and full wound closure products. This segment?s products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers; and products for the treatment of wounds, including burns and invasive surgery. The company serves medical and surgical service providers. Smith & Nephew plc was founded in 1856 and is headquartered in London, the United Kingdom.

Advisors' Opinion:
  • [By James Brumley]

    All that being said, while St. Jude Medical might have never been known as a device pioneer, the acquisitions of Nanostim and Endosense have given STJ stock holders some exposure to pacemakers without pesky leads (where the “pulse” is created), and exposure to atrial fibrillation treatment without the use of drugs. This year might mark a serious upgrade for the company’s product lines.

    Medical Devices: Smith & Nephew plc (SNN)

    Priced at a trailing P/E of 24 and a forward-looking P/E of 17, it’s not like you can call Smith & Nephew plc (SNN) a screaming value. It’s a reliable growth machine, however, in terms of earnings as well as revenue.

  • [By Jake L'Ecuyer]

    Top Headline
    Smith & Nephew PLC (NYSE: SNN) announced its plans to buy ArthroCare (NASDAQ: ARTC) for $1.7 billion in cash. Smith & Nephew will pay $48.25 per share in cash to acquire ArthroCare, representing a 6.3% premium to ArthroCare's closing price on January 31.

  • [By Dan Carroll]

    British device maker Smith & Nephew (NYSE: SNN  ) is the latest company�to join the emerging markets push. The company announced it agreed to buy Indian trauma device maker Adler Mediequip, which -- along with the buyout of a Brazilian�distribution partner -- totaled around $70 million. What does this mean for your investment and the medical device industry's emerging markets momentum?

Top 5 Dividend Stocks To Buy Right Now: HCP Inc. (HCP)

HCP, Inc. is an independent hybrid real estate investment trust. The fund invests in real estate markets of the United States. It primarily invests in properties serving the healthcare industry including sectors of healthcare such as senior housing, life science, medical office, hospital and skilled nursing. The fund also invests in mezzanine loans and other debt instruments. It engages in acquisition, development, leasing, selling and managing of healthcare real estate and provides mortgage and other financing to healthcare providers. The fund benchmarks the performance of its portfolio against the S&P 500 Index, Berkshire Hathaway Index, and MSCI REIT Index. HCP, Inc. was formed in 1985 and is based in Long Beach, California with additional office in Nashville and San Francisco.

Advisors' Opinion:
  • [By Roberto Pedone]

    You don't have to be an expert technical analyst to see what's going on in shares of health care REIT HCP (HCP). This stock is in stuck in a textbook downtrending channel. Fundamentally, there's a lot to like about this stock, but HCP is a good example of why it's never a good idea to chase yield; HCP may have a 5.29% annual dividend payout, but shares have lost more than that in the last month alone.

    HCP's price channel has provided traders with a high-probability range for shares since the middle of the year. Despite the last four attempts at pushing through trendline resistance, shares have been swatted down on each attempt. And while HCP has been turning higher in the last few sessions, investors should look at trendline resistance at $42 with a lot of skepticism. That's probably the worst possible time to be a buyer.

    Instead, it makes sense to sell near the trendline for a most efficient exit in HCP. Yes, trendlines do eventually break, but getting in now is a big mistake. After all "this time it's different" are probably the most expensive four words in the English language. As long as shares stay within that channel, sell the bounce.

  • [By Dimitra DeFotis]

    Among real estate trusts:

    American Tower��(AMT),�the diversified �REIT, is the best performer in the index.�It was�up 4.6% after saying�Friday it will buy the parent of tower operator Global Tower Partners for $4.8 billion. HCP (HCP), a healthcare REIT, was�up 3.3%. Prologis (PLD) an industrial REIT, was�up 2.8%. Vornado Realty Trust (VNO) was�up 2.7%. Boston Properties (BXP), the office REIT, was�up 2.3%. Equity Residential (EQR), a residential REIT, was�up 2.4%. Ventas (VTR), a healthcare REIT, was�up 2%.

     

  • [By Sure Dividend]

    Health care will be necessary until we find a cure for everything. There is a less than infinitesimal chance of us finding a cure for everything in the next several decades. The following companies are Dividend Aristocrats whose revenue is generated primarily in the health care sector:

    HCP, Inc. (HCP) AbbVie (ABBV) Johnson & Johnson (JNJ) Abbott Laboratories (ABT) Walgreen (WAG) Medtronic (MDT) Becton Dickinson (BDX) Cardinal Health (CAH) C.R. Bard (BCR)

    Not to be outdone by the food and beverage industry (or perhaps due to negative health effects from the food and beverage industry), the health care industry counts nine Dividend Aristocrats in its ranks. They operate in more diverse lines of business than the food companies. HCP is a REIT that focuses on health care properties. C.R. Bard, Medtronic, and Becton Dickinson manufacture and distribute health care devices and supplies. Abbott Laboratories and Johnson & Johnson (and to a lesser extent, Cardinal Health) are well-diversified health care businesses. AbbVie was recently spun-off from Abbott Laboratories (notice the vaguely similar names), and is a pharmaceutical company.

  • [By Jim Fink]

    Year-to-Date Performance

    Industry Diamond Offshore (NYSE: DO) $55.39 $7.7 billion 3.3 -14.2% Oil Drilling HCP Inc. (NYSE: HCP) $36.22 $16.5 billion 3.5 -16.0% Healthcare REIT American Realty Capital Properties (Nasdaq: ARCP) $12.64 $2.4 billion 8.6 1.9% Retail and Office REIT Southern Co. (NYSE: SO) $40.88 $36.1 billion 9.8 -0.1% Electric Utility Cooper Tire & Rubber (NYSE: CTB) $22.01 $1.4 billion 10.3 -11.8% Automobile Tires CenturyLink (NYSE: CTL) $31.36 $18.5 billion 11.8 -14.5% Telecommunications Quest Diagnostic (NYSE: DGX) $54.05 $7.8 billion 13.4 -5.4% Medical Diagnostic Tests Kinder Morgan Energy Partners (NYSE: KMP) $79.57 $34.9 billion 15.4 6.0% Energy pipeline MLP Altera (Nasdaq: ALTR) $31.98 $10.3 billion 15.9 -5.6% Semiconductors ADT Corp. (NYSE: ADT) $40.01 $8.0 billion 16.8 -12.9% Home Security

    Source: Bloomberg

Top 5 Dividend Stocks To Buy Right Now: Freeport-McMoran Copper & Gold Inc.(FCX)

Freeport-McMoRan Copper & Gold Inc. engages in the exploration, mining, and production of mineral resources. The company primarily explores for copper, gold, molybdenum, silver, and cobalt. It holds interests in various properties, located in North and South America; the Grasberg minerals district in Indonesia; and the Tenke Fungurume minerals district in the Democratic Republic of Congo. As of December 31, 2010, the company?s consolidated recoverable proven and probable reserves totaled 120.5 billion pounds of copper, 35.5 million ounces of gold, 3.39 billion pounds of molybdenum, 325.0 million ounces of silver, and 0.75 billion pounds of cobalt. The company was founded in 1987 and is headquartered in Phoenix, Arizona.

Advisors' Opinion:
  • [By Arjun Sreekumar]

    Apache to sell Gulf of Mexico interests and assets
    On May 8, Apache announced that it will sell its nonoperated interests in the Lucius and Heidelberg development projects, two massive Gulf of Mexico deepwater projects operated by Anadarko Petroleum� (NYSE: APC  ) , as well as 11 deepwater exploration blocks to Freeport-McMoRan Copper & Gold (NYSE: FCX  ) for $1.4 billion. The transaction is expected to close by June 30, 2014.

  • [By Rich Duprey]

    Gold and copper miner�Freeport-McMoRan� (NYSE: FCX  ) has completed its acquisition of Plains Exploration & Production (NYSE: PXP  ) and, as previously planned, the board of directors says it will pay investors a supplemental dividend of $1.00 per share that is in addition to the regular quarterly payout of $0.3125 per share.

  • [By Rich Duprey]

    After a near-two month delay, copper and gold miner Freeport-McMoRan (NYSE: FCX  ) has begun running copper shipments again out of�its Grasberg mine in Indonesia, though full capacity production is still at least a month away.

No comments:

Post a Comment